| Literature DB >> 28916303 |
Mei Ding1, Karin Kaspersson2, David Murray3, Catherine Bardelle4.
Abstract
Flow cytometry is a technology providing multiparametric analysis of single cells or other suspension particles. High-throughput (HT) flow cytometry has become an attractive screening platform for drug discovery. In this review, we highlight the recent HT flow cytometry applications, and then focus on HT flow cytometry deployment at AstraZeneca (AZ). Practical considerations for successful HT flow cytometry assay development and screening are provided based on experience from four project case studies at AZ. We provide an overview of the scientific rationale, explain why HT flow cytometry was chosen and how HT flow cytometry assays deliver new ways to support the drug discovery process.Mesh:
Year: 2017 PMID: 28916303 DOI: 10.1016/j.drudis.2017.09.005
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851